Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter study of deferasirox after allogeneic hematopoietic progenitor transplantation
2008-003207-30Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of deferasirox in transfusional hemosiderosis, sponsored by Novartis. Primary endpoint: Mean change in serum ferritin after 52 weeks. Started Jul 2008; status: completed.
02
Drugs
deferasirox
03
Conditions
transfusional hemosiderosis
Beyond the preview
Go deeper on 2008-003207-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003207-30.